IssuerAnnouncementDetailsV2Portlet
Actions
Dallah Healthcare Co. announces to Invites its Shareholders to Attend the (First Meeting) Extraordinary General Assembly Meeting
| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of Dallah Healthcare Company is pleased to invite its shareholders to participate and vote in the Extraordinary General Assembly Meeting (the first meeting) |
| City and Location of the General Assembly's Meeting | Riyadh - Head Office - By Means of Modern Technology |
| URL for the Meeting Location | www.tadawulaty.com.sa |
| Date of the General Assembly's Meeting | 2023-12-28 Corresponding to 1445-06-15 |
| Time of the General Assembly's Meeting | 19:30 |
| Attendance Eligibility | Shareholders registered in the Company’s Shareholders registry at the Depository Center “Edaa” at the end of the trading session preceding the General Assembly’s Meeting are eligible to attend in accordance with Laws and Regulations. |
| Quorum for Convening the General Assembly's Meeting | According to Article 34 of the Company’s Bylaws, the meeting of the Extraordinary General Assembly shall not be valid unless attended by shareholders representing at least half of the capital, If this quorum is not met during the first meeting, a second meeting will be held within one hour of the scheduled time for the first meeting, and the second meeting will be valid if attended by shareholders representing at least one quarter of the capital. |
| General Assembly Meeting Agenda | 1- Voting on amending the company's bylaw to comply with the new companies' law, rearranging the bylaw, and numbering them to comply with the proposed amendments. 2- Voting on the amendment of Article No. (3) of the company's bylaws related to (the company's objectives). (attached) 3- Voting on the company’s purchase of a number of its shares and a maximum of (3,826,189)shares and keep them as treasury shares, to cover future swaps, for the acquisition of a company shares or stakes or an asset purchase. The purchase will be financed from the company’s own resources and authorizing the Board of Directors to complete the process within 12 months of the extraordinary general assembly’s approval date, and the company will keep the purchased shares for a maximum period of (5) years from the date of approval of the extraordinary general assembly. After the expiry of this period, the company will follow the procedures and controls stipulated in the relevant laws and regulations. (attached) 4- Voting on the amendment on the Audit Committee Charter. (attached) 5- Voting on the amendment on the Policies, Standards and Procedures for Membership of Board of Directors. (attached) |
| Proxy Form |  |
| The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right. (Mentioning the E-Voting details, if any) | Shareholders are entitled to discuss matters listed in the agenda of the general assembly and raise relevant questions to the board members. Shareholders registered in Tadawulaty service will be able to vote electronically on the general assembly’s agenda. Electronic voting will start Sunday at 1:00AM, 11/06/1445 AH Corresponding to 24/12/2023, and will last until the end of the General assembly time. Please note that registration in Tadawulaty service and voting is free of charge for all Shareholders via: |
| Eligibility for Attendance Registration and Voting | Eligibility for Registering the Attendance of the General Assembly's Meeting Ends upon the Convenience of the General Assembly's Meeting. Eligibility for Voting on the Business of the Meeting Agenda Ends upon the Counting Committee Concludes Counting the Votes |
| Method of Communication | In case of any inquiries or questions regarding the meeting schedule, please contact the Investors Relations Department: Telephone: +966 11 2255065 (5769, 5001) Fax: +966 11 4550803 Email: IR@Dallahhealth.com |
| Attached Documents | |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 129.9
Net Change 1.3 (+1.01%)
Value Traded (Sar) 2,529,626.9
Volume Traded 19,511
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions